Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | TTR | P02766 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3028363 | 1.00 | PTGS1 (0.47) | PTGS1PTGS2MAOBADORA2ALMNA | |
| SCHEMBL3641850 | 0.93 | HSD17B1 (0.55) | PTGS1PTGS2MAOBLMNAMAPT | |
| SCHEMBL16687974 | 0.91 | MAOB (0.49) | MAOBADORA2ALMNAMAPTKMT2A | |
| SCHEMBL8589165 | 0.89 | LMNA (0.53) | MAOBADORA2ALMNAMAPTKMT2A | |
| SCHEMBL8589167 | 0.89 | LMNA (0.53) | MAOBADORA2ALMNAMAPTKMT2A | |
| SCHEMBL3030012 | 0.88 | TTR (0.55) | PTGS1PTGS2MAOBLMNAMAPT | |
| SCHEMBL3030016 | 0.88 | TTR (0.55) | PTGS1PTGS2MAOBLMNAMAPT | |
| SCHEMBL18860733 | 0.84 | PTGS1 (0.61) | PTGS1PTGS2MAOBLMNAMAPT | |
| SCHEMBL18860735 | 0.84 | PTGS1 (0.61) | PTGS1PTGS2MAOBLMNAMAPT | |
| SCHEMBL6555140 | 0.81 | LMNA (0.65) | PTGS1PTGS2MAOBLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2679243-B1 | Co-precipitate of one or more stilbene polyphenols in lamellar anionic solids, it's applications and related preparation method | FIORETTI BERNARD (IT) | 2017-05-24 | — | — | EP | claimed |
| US-8912234-B2 | Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol | UNIAO Brasileria de Educacao e Assistencia—Mantenedora da PUCRS (BR) | 2014-12-16 | — | — | US | claimed |
| US-20130040920-A1 | COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL | UNIAO Brasileira de Educacao e Assistencia- Matenedora da PUCRS (BR) | 2013-02-14 | — | — | US | claimed |
| US-20100204179-A1 | Resveratrol complex and process for the preperation | UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA - MANTENEDORA DA PUCRS (BR) | 2010-08-12 | — | — | US | claimed |
| US-20230061229-A1 | SMART WOUND DRESSINGS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2023-03-02 | — | — | US | disclosed |
| EP-2679243-B1 | Co-precipitate of one or more stilbene polyphenols in lamellar anionic solids, it's applications and related preparation method | FIORETTI BERNARD (IT) | 2017-05-24 | — | — | EP | disclosed |
| US-8912234-B2 | Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol | UNIAO Brasileria de Educacao e Assistencia—Mantenedora da PUCRS (BR) | 2014-12-16 | — | — | US | disclosed |
| US-8476248-B2 | Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof | Uniao Brasileira de Educacao e Assistencia—Mantenedora da PUCRS (BR) | 2013-07-02 | — | — | US | disclosed |
| US-20130040920-A1 | COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL | UNIAO Brasileira de Educacao e Assistencia- Matenedora da PUCRS (BR) | 2013-02-14 | — | — | US | disclosed |
| US-20100204179-A1 | Resveratrol complex and process for the preperation | UNIÃO BRASILEIRA DE EDUCAÇÃO E ASSISTÊNCIA - MANTENEDORA DA PUCRS (BR) | 2010-08-12 | — | — | US | disclosed |
| EP-2178525-A1 | RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION | União Brasileira De Educação E Assistência - Mantenedora Da Pucrs (BR) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009012551-A1 | RESVERATROL COMPLEX AND PROCESS FOR THE PREPERATION | UNIÄO BRASILEIRA DE EDUCAÇAO E ASSITENCIA-MANTENEDORA DA PUCRS (BR) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040920-A1 | COMPOSITION CONTAINING RESVERATROL AND/OR DERIVATIVES THEREOF AND PLANT OIL, PROCESS FOR PRODUCING SAID COMPOSITION, NUTRACEUTICAL AND/OR PHARMACEUTICAL PRODUCT, AND METHOD FOR ENHANCING THE POTENTIAL OF RESVERATROL | GPR119, MAVS, SIRT1 | PTGS1 1237/4885PTGS2 1099/4885MAOB 1756/4885 |
| US-20100204179-A1 | Resveratrol complex and process for the preperation | SI, GPR119, GYS1 | PTGS1 1477/4885PTGS2 3134/4885MAOB 4453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.